Organization
Sumitomo Dainippon Pharma
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Sumitomo Dainippon Pharma
... incorporate are Johnson & Johnson, Otsuka Pharmaceuticals, AstraZeneca, Eli Lilly, Alkermes, Sumitomo Dainippon Pharma, Pfizer, Vanda Pharmaceuticals and Allergan (Forest Labs)/ Geodon Ritcher. Request a ...
... a division of the American Chemical Society (ACS), announced today that Sumitomo Dainippon Pharma has signed a 5-year agreement to provide enterprise-wide access to the ...
... 2018 2017 2017 2017 Roivant Agreement 8.1 - 8.1 - - - Sumitomo Agreement 10.2 19.2 29.4 - - - Total revenues 18.3 19.2 37.5 ...
... Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Hiroshi Nomura ) announced today ...
... Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi ...
... in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion ...
... in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion ...
... in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion ...
... study," said Thomas Kuhn, CEO of Poxel. "Working with our partner Sumitomo Dainippon Pharma, we have made significant progress advancing the Phase 3 Trialsof IMeglimin ...
Subscribe now for full coverage on Sumitomo Dainippon Pharma
Start My Free Trial